WNY Asset Management’s AbbVie ABBV Stock Holding History

WNY Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Buy	4,347 +19	+0.4%	+$4.09K	0.1%	98
2026 Q1	$941K	Buy	+4,328	New	+$960K	0.1%	106
2025 Q3	$1.04M	Buy	4,475 +1,002	+29%	+$204K	0.1%	94
2025 Q2	$645K	Sell	3,473 -533	-13%	-$99.1K	0.07%	117
2025 Q1	$839K	Buy	4,006 +16	+0.4%	+$3.11K	0.1%	101
2024 Q4	$709K	Sell	3,990 -517	-11%	-$95.1K	0.09%	107
2024 Q3	$890K	Sell	4,507 -540	-11%	-$101K	0.1%	98
2024 Q2	$866K	Buy	5,047 +142	+3%	+$23.5K	0.11%	101
2024 Q1	$893K	Buy	4,905 +262	+6%	+$45.2K	0.14%	98
2023 Q4	$719K	Sell	4,643 -17	-0.4%	-$2.48K	0.12%	111
2023 Q3	$695K	Buy	4,660 +98	+2%	+$14.4K	0.14%	99
2023 Q2	$615K	Sell	4,562 -194	-4%	-$28.4K	0.13%	101
2023 Q1	$758K	Sell	4,756 -741	-13%	-$113K	0.18%	88
2022 Q4	$888K	Sell	5,497 -1,007	-15%	-$154K	0.24%	74
2022 Q3	$871K	Sell	6,504 -3,514	-35%	-$504K	0.32%	64
2022 Q2	$1.53M	Buy	10,018 +2,576	+35%	+$394K	0.52%	48
2022 Q1	$1.2M	Sell	7,442 -710	-9%	-$103K	0.37%	61
2021 Q4	$1.11M	Sell	8,152 -285	-3%	-$33.7K	0.33%	61
2021 Q3	$909K	Buy	8,437 +690	+9%	+$78.8K	0.31%	66
2021 Q2	$873K	Buy	7,747 +2,060	+36%	+$232K	0.31%	64
2021 Q1	$615K	Buy	5,687 +2,175	+62%	+$233K	0.25%	68
2020 Q4	$374K	Buy	+3,512	New	+$337K	0.19%	58

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WNY Asset Management's ABBV Position: Q2 2026 in Review

WNY Asset Management increased its AbbVie (ABBV) stake by 0.44% in Q2 2026, buying an estimated $4.09K and bringing the position to 4,347 shares worth $1.09M. The position accounts for 0.1% of the portfolio, ranked #98.

WNY Asset Management first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.53M in Q2 2022. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

WNY Asset Management held 4,347 shares of AbbVie worth $1.09M as of Q2 2026.
WNY Asset Management bought 19 AbbVie shares in Q2 2026, an estimated $4.09K.
AbbVie made up 0.1% of WNY Asset Management's portfolio in Q2 2026, its #98 holding.
WNY Asset Management first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
WNY Asset Management's AbbVie position peaked at $1.53M in Q2 2022.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on WNY Asset Management's 13F filing for Q2 2026, filed 17 Aug 2026.